Overview

Most people who take vitamin supplements do so with the reasonable expectation that the nutrients they ingest will reach the tissues that need them. For most vitamins, a meaningful proportion does — digestive absorption, however imperfect, delivers enough of what is taken orally to maintain adequate tissue levels. For glutathione, the situation is more complicated. Glutathione is a tripeptide — a molecule composed of three amino acids — that is largely degraded by digestive enzymes in the gut before it can be absorbed intact. The plasma concentrations achievable through oral glutathione supplementation, regardless of dose, are a fraction of the tissue concentrations achievable through intravenous delivery. This is not a supplement industry failure. It is a pharmacokinetic reality — and it is the reason that the clinical effects consistently attributed to glutathione in research settings are effects demonstrated at IV delivery concentrations, not at the concentrations oral supplementation achieves.

Intravenous delivery bypasses the gut entirely. Glutathione administered intravenously enters the bloodstream directly, reaching plasma and tissue concentrations that are biologically meaningful — activating the antioxidant, detoxification, and melanin-regulatory functions of glutathione at the cellular level in ways that oral supplementation, however faithfully maintained, cannot replicate. At Ministry of Skin, Glutathione IV Infusion is administered within a medically supervised programme, with dosing prescribed by a dermatologist following a pre-infusion health assessment, and every infusion delivered by a qualified medical professional in a clinical setting.

The clinical applications of glutathione — for skin luminosity, pigmentation management, antioxidant protection, and the systemic health benefits of the body's master antioxidant at therapeutic concentrations — are the reason it has become one of the most requested IV treatments at Ministry of Skin. They are also the reason it is administered as a clinical programme rather than a cosmetic service.

What Glutathione Actually Does

At the cellular level, glutathione performs three functions that are directly relevant to skin health and appearance. As the body's primary intracellular antioxidant, it neutralises reactive oxygen species — the free radicals generated by UV exposure, pollution, metabolic activity, and oxidative stress — that would otherwise damage cellular proteins, lipid membranes, and DNA, and that drive the collagen degradation and accelerated ageing associated with cumulative environmental exposure. As a cofactor for glutathione peroxidase and other enzymatic detoxification systems, it supports the clearance of metabolic waste and environmental toxins from the cellular environment. And as a direct inhibitor of tyrosinase — the enzyme that catalyses the rate-limiting step in melanin synthesis — it reduces melanin production at the source, producing a progressive and even reduction in melanin across all melanocyte-containing tissue.

The melanin-inhibitory effect of glutathione is mediated through tyrosinase inhibition and through a secondary mechanism — shifting the type of melanin produced from eumelanin, the darker form, toward phaeomelanin, the lighter form. The combined effect of reduced melanin production and altered melanin type produces the progressive brightening of skin tone and improvement in pigmentation evenness that patients who maintain a consistent glutathione IV programme describe. This is not a bleaching effect — it is a modulation of the melanogenesis pathway that reduces overproduction of pigment while maintaining the skin's natural melanin system intact.